PMID- 30641751 OWN - NLM STAT- MEDLINE DCOM- 20190513 LR - 20190513 IS - 1878-0334 (Electronic) IS - 1871-4021 (Linking) VI - 13 IP - 1 DP - 2019 Jan-Feb TI - Increased insulin requirement may contribute to risk of obesity in children and young people with Type 1 Diabetes Mellitus. PG - 492-495 LID - S1871-4021(18)30444-2 [pii] LID - 10.1016/j.dsx.2018.11.005 [doi] AB - INTRODUCTION: Type 1 diabetes mellitus (T1DM) is an autoimmune disorder that interferes with the function of the beta cells in the pancreas. Reports show that the incidence of T1DM is increasing throughout England and Wales, along with the Body Mass Index (BMI) of this patient group. The association between type 2 diabetes mellitus (T2DM) and obesity is recognised, but literature describing the association between T1DM and high BMI is more limited. The aim of this paper is to identify factors affecting BMI and the impact that this increasing trend has on children and young people with T1DM. METHODS: Information was obtained from the medical records of patients with T1DM at the local paediatric centre. BMI standard deviation scores (SDS) were calculated and compared to other factors, which include insulin requirement, HbA1c, pubertal status and age at diagnosis. RESULTS: This study involved 102 patients (43 male and 59 female). The mean age at diagnosis was 7.79 years (range from 0.16 to 16.91 years). Our results showed a significant association between insulin requirement and BMI SDS (r = 0.23, p = 0.02) and a significant association between insulin requirement and mean HbA1c (r = 0.59, p=<0.01). A multivariable regression analysis of factors affecting BMI SDS showed that insulin requirement was an independent factor affecting BMI SDS. CONCLUSION: There were significant associations between increased insulin requirement, high BMI SDS and poorer glycaemic control. Further research is required to fully understand the risk factors that may contribute to obesity in T1DM. CI - Copyright (c) 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved. FAU - Apperley, Louise J AU - Apperley LJ AD - Department of Paediatrics, Southport and Ormskirk NHS Trust, Wigan Road, Ormskirk, L39 2AZ, UK. FAU - Ng, Sze May AU - Ng SM AD - Department of Paediatrics, Southport and Ormskirk NHS Trust, Wigan Road, Ormskirk, L39 2AZ, UK; Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Crown Street, L8 7SS, Liverpool, UK. Electronic address: may.ng@nhs.net. LA - eng PT - Journal Article DEP - 20181103 PL - Netherlands TA - Diabetes Metab Syndr JT - Diabetes & metabolic syndrome JID - 101462250 RN - 0 (Biomarkers) RN - 0 (Hypoglycemic Agents) RN - 0 (Insulin) SB - IM MH - Adolescent MH - Biomarkers/analysis MH - Body Mass Index MH - Child MH - Child, Preschool MH - Diabetes Mellitus, Type 1/*complications/drug therapy MH - Female MH - Follow-Up Studies MH - Humans MH - Hypoglycemic Agents/administration & dosage/*metabolism MH - Infant MH - Insulin/administration & dosage/*metabolism MH - *Insulin Resistance MH - Male MH - Pediatric Obesity/*etiology/pathology MH - Prognosis OTO - NOTNLM OT - Glycemic control OT - Insulin requirement OT - Obesity OT - Type 1 Diabetes Mellitus EDAT- 2019/01/16 06:00 MHDA- 2019/05/14 06:00 CRDT- 2019/01/16 06:00 PHST- 2018/09/17 00:00 [received] PHST- 2018/11/02 00:00 [accepted] PHST- 2019/01/16 06:00 [entrez] PHST- 2019/01/16 06:00 [pubmed] PHST- 2019/05/14 06:00 [medline] AID - S1871-4021(18)30444-2 [pii] AID - 10.1016/j.dsx.2018.11.005 [doi] PST - ppublish SO - Diabetes Metab Syndr. 2019 Jan-Feb;13(1):492-495. doi: 10.1016/j.dsx.2018.11.005. Epub 2018 Nov 3.